» Articles » PMID: 37077698

Current Status of Machine Learning in Thyroid Cytopathology

Overview
Journal J Pathol Inform
Date 2023 Apr 20
PMID 37077698
Authors
Affiliations
Soon will be listed here.
Abstract

The implementation of Digital Pathology has allowed the development of computational Pathology. Digital image-based applications that have received FDA Breakthrough Device Designation have been primarily focused on tissue specimens. The development of Artificial Intelligence-assisted algorithms using Cytology digital images has been much more limited due to technical challenges and a lack of optimized scanners for Cytology specimens. Despite the challenges in scanning whole slide images of cytology specimens, there have been many studies evaluating CP to create decision-support tools in Cytopathology. Among different Cytology specimens, thyroid fine needle aspiration biopsy (FNAB) specimens have one of the greatest potentials to benefit from machine learning algorithms (MLA) derived from digital images. Several authors have evaluated different machine learning algorithms focused on thyroid cytology in the past few years. The results are promising. The algorithms have mostly shown increased accuracy in the diagnosis and classification of thyroid cytology specimens. They have brought new insights and demonstrated the potential for improving future cytopathology workflow efficiency and accuracy. However, many issues still need to be addressed to further build on and improve current MLA models and their applications. To optimally train and validate MLA for thyroid cytology specimens, larger datasets obtained from multiple institutions are needed. MLAs hold great potential in improving thyroid cancer diagnostic speed and accuracy that will lead to improvements in patient management.

Citing Articles

Study on the Transformation Process of Thyroid Fine-Needle Aspiration Liquid-Based Cytology to Whole-Slide Image.

Lei Y, Wang D, Wen Y, Liu J, Cao J Cytopathology. 2025; 36(2):106-114.

PMID: 39780471 PMC: 11810536. DOI: 10.1111/cyt.13468.


AI in Cytopathology: A Narrative Umbrella Review on Innovations, Challenges, and Future Directions.

Giansanti D J Clin Med. 2024; 13(22).

PMID: 39597889 PMC: 11594881. DOI: 10.3390/jcm13226745.


Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease.

Luvhengo T, Moeng M, Sishuba N, Makgoka M, Jonas L, Mamathuntsha T Cancers (Basel). 2024; 16(20).

PMID: 39456563 PMC: 11505703. DOI: 10.3390/cancers16203469.


A novel computational pathology approach for identifying gene signatures prognostic of disease-free survival for papillary thyroid carcinomas.

Monabbati S, Khalighi S, Fu P, Shi Q, Asa S, Madabhushi A Eur J Cancer. 2024; 212:114326.

PMID: 39307037 PMC: 11531387. DOI: 10.1016/j.ejca.2024.114326.


Minimally invasive biopsy-based diagnostics in support of precision cancer medicine.

Franzen B, Auer G, Lewensohn R Mol Oncol. 2024; 18(11):2612-2628.

PMID: 38519839 PMC: 11547246. DOI: 10.1002/1878-0261.13640.


References
1.
Dikici E, Bigelow M, Prevedello L, White R, Erdal B . Integrating AI into radiology workflow: levels of research, production, and feedback maturity. J Med Imaging (Bellingham). 2020; 7(1):016502. PMC: 7012173. DOI: 10.1117/1.JMI.7.1.016502. View

2.
Elliott Range D, Dov D, Kovalsky S, Henao R, Carin L, Cohen J . Application of a machine learning algorithm to predict malignancy in thyroid cytopathology. Cancer Cytopathol. 2020; 128(4):287-295. DOI: 10.1002/cncy.22238. View

3.
Haugen B . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?. Cancer. 2016; 123(3):372-381. DOI: 10.1002/cncr.30360. View

4.
Kim D, Burkhardt R, Alperstein S, Gokozan H, Goyal A, Heymann J . Evaluating the role of Z-stack to improve the morphologic evaluation of urine cytology whole slide images for high-grade urothelial carcinoma: Results and review of a pilot study. Cancer Cytopathol. 2022; 130(8):630-639. DOI: 10.1002/cncy.22595. View

5.
Cochand-Priollet B, Koutroumbas K, Megalopoulou T, Pouliakis A, Sivolapenko G, Karakitsos P . Discriminating benign from malignant thyroid lesions using artificial intelligence and statistical selection of morphometric features. Oncol Rep. 2006; 15 Spec no.:1023-6. DOI: 10.3892/or.15.4.1023. View